A Phase II, Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma (CTMS# 20-0148)

Cancer Type

Neuroblastoma

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

William Kelly, MD

For more information about this study

View Details